259 results
Page 2 of 13
8-K
EX-99.1
z3d6ussz
3 Aug 22
Ampio Pharmaceuticals’ Chairman of the Board Kevin Buchi and CEO Mike Martino Issues Letter to Stockholders
8:36am
8-K
EX-99.1
zaarv6z0
2 Jun 22
Ampio Pharmaceuticals’ CEO Mike Martino Issues Letter to Stockholders
4:35pm
8-K
EX-99.1
gltky1ln pvoupksr
16 May 22
Results of Operations and Financial Condition
12:00am
8-K
EX-99.2
9si8u7fbk
16 May 22
Results of Operations and Financial Condition
12:00am
8-K
aczq61wdu
28 Apr 22
Conference Call Script
8:00am
8-K
EX-99.1
tvymgeqy
20 Apr 22
Ampio Provides Regulatory Update
9:43pm
8-K
EX-99.1
ro79cpvm7vuvee67
29 Mar 22
Ampio Pharmaceuticals Reports Fourth-Quarter and Full-Year 2021 Financial Results and Operational Highlights
4:17pm
8-K
EX-99.1
hccagv3kiu
2 Mar 22
Complete analysis of AP-013 data show Ampion reduced pain with statistical significance
4:38pm
8-K
EX-99.1
9lsn8au6c59r7r3jcygc
10 Feb 22
Entry into a Material Definitive Agreement
4:01pm
8-K
EX-99.1
6vslxw4
16 Dec 21
Regulation FD Disclosure
4:01pm
8-K
EX-99.1
tp9jpdk
15 Dec 21
Entry into a Material Definitive Agreement
12:00am
8-K
EX-10.1
c6hxcscy7
15 Dec 21
Entry into a Material Definitive Agreement
12:00am
8-K
EX-10.2
z1ivmzr142hs2fh0 cvd
15 Dec 21
Entry into a Material Definitive Agreement
12:00am
424B5
25ro nj2jb7pd1cw44zv
14 Dec 21
Prospectus supplement for primary offering
5:06pm
8-K
EX-10.1
1z3dd1nk9f98079 90b
29 Nov 21
Departure of Directors or Certain Officers
4:01pm
8-K
EX-99.1
8c0hxp4lwphl48nr ox
29 Nov 21
Departure of Directors or Certain Officers
4:01pm